Program

Dr. Landay joined the faculty at Rush University Medical Center in 1983 and helped establish the HIV research program which has grown to encompass both a basic and clinical focus on immune studies in HIV.  Dr. Landay served as Chair of the National Committee of Clinical Laboratory Standards Committee on Flow Cytometry which produced the first national standard on CD4 testing.  He has also served as an advisor to the College of American Pathologists, NIH and WHO on Standardization of CD4 Testing and serves on the Bill and Melinda Gates Foundation Global Health Care Technologies Committee.  Dr. Landay's current research focus is on immune pathogenesis and immune based therapy of HIV disease and he is past Chair of the Immunology Research Agenda Committee of the AIDS Clinical Trial Group NIH Program and he has served on the Executive Committee of the Forum for HIV Collaborative Research.  Dr. Landay is Chair of the NIH Office of AIDS Research Panel on Pathogenesis and PI of the Chicago Developmental Center for AIDS Research.  He is also Chair of the Women's Interagency HIV Studies Science Committee.  He serves on NIH, AmFar, Glazer Pediatric AIDS Foundation and State of California Grant grant review panels and Chair's the NIH HIV Vaccine Study Section.  He has served as a mentor for over 15 graduate students and postdoctoral fellows who have gone on to obtain academic positions.  Dr. Landay has published over 280 peer reviewed papers focused on basic and clinical studies of HIV.